| Title |
Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas
|
|---|---|
| Published in |
Journal of Neuro-Oncology, August 2008
|
| DOI | 10.1007/s11060-008-9663-9 |
| Pubmed ID | |
| Authors |
Stefano Dall’Oglio, Anna D’Amico, Fabio Pioli, Milena Gabbani, Felice Pasini, Maria Grazia Passarin, Andrea Talacchi, Sergio Turazzi, Sergio Maluta |
| Abstract |
We performed a new phase II trial enrolling patients with newly diagnosed high-grade glioma (HGG) to test the efficacy of a weekly alternating temozolomide (TMZ) schedule after surgery and concomitant chemoradiotherapy. |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Nepal | 1 | 2% |
| India | 1 | 2% |
| Unknown | 47 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 9 | 18% |
| Student > Master | 7 | 14% |
| Student > Doctoral Student | 5 | 10% |
| Professor > Associate Professor | 4 | 8% |
| Student > Postgraduate | 3 | 6% |
| Other | 9 | 18% |
| Unknown | 12 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 39% |
| Neuroscience | 4 | 8% |
| Agricultural and Biological Sciences | 4 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
| Engineering | 2 | 4% |
| Other | 6 | 12% |
| Unknown | 12 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2019.
All research outputs
#7,453,126
of 22,785,242 outputs
Outputs from Journal of Neuro-Oncology
#1,040
of 2,965 outputs
Outputs of similar age
#29,389
of 83,449 outputs
Outputs of similar age from Journal of Neuro-Oncology
#6
of 13 outputs
Altmetric has tracked 22,785,242 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,965 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,449 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.